Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
C-X-C motif chemokine ligand 2 (CXCL2) is a small secreted protein that exhibits a structure similar to the proangiogenic subgroup of the CXC chemokine family. Recently, accumulating evidence suggests that chemokines play a pivotal role in cancer progression and carcinogenesis. We examined the expression levels of 7 types of ELR＋ CXCLs messenger RNA (mRNA) in 264 clinical samples. We found that CXCL2 expression was stably down-regulated in 94% of hepatocellular carcinoma (HCC) specimens compared with paired adjacent normal liver tissues and some HCC cell lines. Moreover, CXCL2 overexpression profoundly attenuated HCC cell proliferation and growth and induced apoptosis in vitro. In animal studies, we found that overexpressing CXCL2 by lentivirus also apparently inhibited the size and weight of subcutaneous tumours in nude mice. Furthermore, we demonstrated that CXCL2 induced HCC cell apoptosis via both nuclear and mitochondrial apoptosis pathways. Our results indicate that CXCL2 negatively regulates the cell cycle in HCC cells via the ERK1/2 signalling pathway. These results provide new insights into HCC and may ultimately lead to the discovery of innovative therapeutic approaches of HCC.
Abstract
C-X-C motif chemokine ligand 2 (CXCL2) is a small secreted protein that exhibits a structure similar to the proangiogenic subgroup of the CXC chemokine family. Recently, accumulating evidence suggests that chemokines play a pivotal role in cancer progression and carcinogenesis. We examined the expression levels of 7 types of ELR＋ CXCLs messenger RNA (mRNA) in 264 clinical samples. We found that CXCL2 expression was stably down-regulated in 94% of hepatocellular carcinoma (HCC) specimens compared with paired adjacent normal liver tissues and some HCC cell lines. Moreover, CXCL2 overexpression profoundly attenuated HCC cell proliferation and growth and induced apoptosis in vitro. In animal studies, we found that overexpressing CXCL2 by lentivirus also apparently inhibited the size and weight of subcutaneous tumours in nude mice. Furthermore, we demonstrated that CXCL2 induced HCC cell apoptosis via both nuclear and mitochondrial apoptosis pathways. Our results indicate that CXCL2 negatively regulates the cell cycle in HCC cells via the ERK1/2 signalling pathway. These results provide new insights into HCC and may ultimately lead to the discovery of innovative therapeutic approaches of HCC.
참고문헌 (32)
- Altekruse SF, "Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005", J Clin Oncol, 27, pp.1485~1491 (1975)
- Siegel RL, "Cancer statistics, 2018", CA Cancer J Clin, 68, pp.7~30 (2018)
- Yuen MF, "Hepatocellular carcinoma in the Asia pacific region", J Gastroenterol Hepatol, 24, pp.346~353 (2009)
- Toso C, "Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence", Am J Transplant, 11, pp.2031~2035 (2011)
- Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
- Mantovani A, "Cancer: Inflaming metastasis", Nature, 457, pp.36~ (2009)
- Mantovani A, "Cancer-related inflammation", J Clin Immol, 454, pp.436~444 (2008)
- Li YW, "Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection", J Hepatol, 54, pp.497~505 (2011)
- Reaux-Le Goazigo A, "Current status of chemokines in the adult CNS", Prog Neurobiol, 104, pp.67~92 (2013)
- Balkwill F, "Cancer and the chemokine network", Nat Rev Cancer, 4, pp.540~550 (2004)
- Smyth MJ, "Cytokines in cancer immunity and immunotherapy", Immol Rev, 202, pp.275~293 (2004)
- Acharyya S, "A CXCL1paracrine network links cancer chemoresistance and metastasis", Cell, 150, pp.165~178 (2012)
- Kollmar O, "Macrophage Inflammatory Protein-2 Promotes Angiogenesis, Cell Migration, and Tumor Growth in Hepatic Metastasis", Ann Surg Oncol, 13, pp.263~275 (2006)
- Hardaway AL, "Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer", Clin Exp Metastasis, 32, pp.353~368 (2015)
- Zhang H, "CXCL2", MIF-CXCR2signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer, 2017, pp.36, 2095~2104
- Lu Y, "Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC", Sci Rep, 6, pp.24558~ (2016)
- Fang LY, "Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling", Cancer Res, 73, pp.5633~5646 (2013)
- Dubois RN, "Role of Inflammation and Inflammatory Mediators in Colorectal Cancer", Trans Am Clin Climatol Assoc, 125, pp.358~ (2014)
- Wolpe SD, "Identification and characterization of macrophage inflammatory protein 2", Proc Natl Acad Sci U S A, 86, pp.612~616 (1989)
- Oppenheim JJ, "Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine Family", Annu Rev Immunol, 9, pp.617~648 (1991)
- Ness TL, "Immunomodulatory role of CXCR2 during experimental septic peritonitis", J Immol, 171, pp.3775~ (2003)
- Song X, "Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC", AmJ Trans Res, 7, pp.2254~2261 (2015)
- Filmus J, "Induction of cyclin D1 overexpression by activated ras", Oncogene, 9, pp.3627~3633 (1994)
- Paternot S, "Rb inactivation in cell cycle and cancer:the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase", Cell Cycle, 9, pp.689~699 (2010)
- Bartkova J, "DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis", Nature, 434, pp.864~870 (2005)
- Tsai LH, "Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase", Nature, 353, pp.174~177 (1991)
- Hunt T, "Under arrest in the cell cycle", Nature, 342, pp.483~484 (1989)
- Nurse P, "Universal control mechanism regulating onset of M-phase", Nature, 344, pp.503~508 (1990)
- Li J, "Caspase in apoptosis and beyond", Oncogene, 276, pp.194~6206 (2008)
- Slee EA, "Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner", J Cell Biol, 144, pp.281~292 (1999)
- Meyer C, "Established and novel NF-B inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC", Oral Oncol, 47, pp.818~826 (2011)
- Liu L, "Sorafenib blocks the RAF", MEK, PRF, pp.5, Cancer Res[DOI]